Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 10 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
Related structures:
AlphaFold database: Q9NF92
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 153 | 155 | PF00675 | 0.539 |
CLV_PCSK_KEX2_1 | 153 | 155 | PF00082 | 0.539 |
CLV_PCSK_SKI1_1 | 99 | 103 | PF00082 | 0.354 |
DOC_MAPK_gen_1 | 97 | 106 | PF00069 | 0.494 |
DOC_MAPK_MEF2A_6 | 20 | 29 | PF00069 | 0.506 |
DOC_PP2B_LxvP_1 | 9 | 12 | PF13499 | 0.713 |
DOC_USP7_MATH_1 | 183 | 187 | PF00917 | 0.756 |
DOC_WW_Pin1_4 | 165 | 170 | PF00397 | 0.731 |
LIG_14-3-3_CanoR_1 | 14 | 22 | PF00244 | 0.679 |
LIG_14-3-3_CanoR_1 | 158 | 164 | PF00244 | 0.699 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.728 |
LIG_EH1_1 | 25 | 33 | PF00400 | 0.429 |
LIG_FHA_1 | 111 | 117 | PF00498 | 0.532 |
LIG_FHA_1 | 49 | 55 | PF00498 | 0.300 |
LIG_LIR_Nem_3 | 21 | 25 | PF02991 | 0.613 |
LIG_Pex14_1 | 22 | 26 | PF04695 | 0.508 |
LIG_Pex14_1 | 86 | 90 | PF04695 | 0.631 |
LIG_Pex14_2 | 102 | 106 | PF04695 | 0.401 |
LIG_SH2_CRK | 60 | 64 | PF00017 | 0.444 |
LIG_SH2_STAT5 | 103 | 106 | PF00017 | 0.379 |
LIG_SH2_STAT5 | 60 | 63 | PF00017 | 0.369 |
LIG_SH2_STAT5 | 89 | 92 | PF00017 | 0.583 |
LIG_SUMO_SIM_anti_2 | 115 | 120 | PF11976 | 0.372 |
LIG_SUMO_SIM_anti_2 | 30 | 36 | PF11976 | 0.441 |
LIG_SUMO_SIM_par_1 | 107 | 113 | PF11976 | 0.291 |
LIG_SUMO_SIM_par_1 | 129 | 135 | PF11976 | 0.363 |
LIG_SUMO_SIM_par_1 | 65 | 70 | PF11976 | 0.323 |
LIG_TRAF2_1 | 146 | 149 | PF00917 | 0.741 |
LIG_UBA3_1 | 83 | 88 | PF00899 | 0.572 |
MOD_CDK_SPxxK_3 | 165 | 172 | PF00069 | 0.718 |
MOD_CK1_1 | 13 | 19 | PF00069 | 0.699 |
MOD_CK1_1 | 168 | 174 | PF00069 | 0.771 |
MOD_CK1_1 | 48 | 54 | PF00069 | 0.357 |
MOD_CK2_1 | 185 | 191 | PF00069 | 0.744 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.417 |
MOD_GlcNHglycan | 160 | 163 | PF01048 | 0.585 |
MOD_GlcNHglycan | 179 | 182 | PF01048 | 0.573 |
MOD_GlcNHglycan | 47 | 50 | PF01048 | 0.646 |
MOD_GlcNHglycan | 69 | 72 | PF01048 | 0.432 |
MOD_GSK3_1 | 164 | 171 | PF00069 | 0.732 |
MOD_GSK3_1 | 177 | 184 | PF00069 | 0.567 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.673 |
MOD_NEK2_1 | 110 | 115 | PF00069 | 0.490 |
MOD_NEK2_1 | 132 | 137 | PF00069 | 0.483 |
MOD_NEK2_1 | 27 | 32 | PF00069 | 0.351 |
MOD_NEK2_1 | 45 | 50 | PF00069 | 0.354 |
MOD_NEK2_1 | 62 | 67 | PF00069 | 0.436 |
MOD_NEK2_1 | 74 | 79 | PF00069 | 0.686 |
MOD_PKA_2 | 13 | 19 | PF00069 | 0.667 |
MOD_PKA_2 | 157 | 163 | PF00069 | 0.738 |
MOD_PKA_2 | 164 | 170 | PF00069 | 0.784 |
MOD_Plk_4 | 132 | 138 | PF00069 | 0.447 |
MOD_Plk_4 | 27 | 33 | PF00069 | 0.398 |
MOD_ProDKin_1 | 165 | 171 | PF00069 | 0.732 |
TRG_ENDOCYTIC_2 | 103 | 106 | PF00928 | 0.453 |
TRG_ENDOCYTIC_2 | 60 | 63 | PF00928 | 0.369 |
TRG_ENDOCYTIC_2 | 89 | 92 | PF00928 | 0.587 |
TRG_ER_diArg_1 | 96 | 99 | PF00400 | 0.491 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4IIQ5 | Bodo saltans | 25% | 100% |
A0A1X0NKT5 | Trypanosomatidae | 34% | 90% |
A0A3R7M187 | Trypanosoma rangeli | 33% | 87% |
A0A3S5H5E3 | Leishmania donovani | 88% | 100% |
A4H417 | Leishmania braziliensis | 47% | 69% |
A4HSA0 | Leishmania infantum | 87% | 100% |
C9ZY95 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 30% | 100% |
E9AK84 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 77% | 100% |